Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：11.205 Date：2022-11-04

Ebiomedicine

Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis

Products： ELK5072
IF：11.2 Date：2024-02-28

Cancer Research

β-catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma

Products： EP013
IF：11.2 Date：2024-05-15

CANCER RESEARCH

β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma

Products： ELK1378
IF：11.15 Date：2023-01-05

BMC Medicine

Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors

Products： EP013、 EQ001

< Page of 352 >